Loading clinical trials...
Loading clinical trials...
Multi-Center Study for the Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
Conditions
Interventions
Standard of Care Medications
Locations
10
United States
Clinical Trial Site
New Haven, Connecticut, United States
Clinical Trial Site
Chicago, Illinois, United States
Clinical Trial Site
Ann Arbor, Michigan, United States
Clinical Trial Site
Nashville, Tennessee, United States
Clinical Trial Site
Seattle, Washington, United States
Clinical Trial Site
Vienna, Austria
Start Date
May 19, 2016
Primary Completion Date
January 21, 2019
Completion Date
January 21, 2019
Last Updated
December 1, 2020
NCT06573723
NCT07046507
NCT06762509
NCT05047523
NCT05792319
NCT06179394
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions